BALDINI, Luca
 Distribuzione geografica
Continente #
NA - Nord America 1.001
EU - Europa 349
AS - Asia 134
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 1.489
Nazione #
US - Stati Uniti d'America 996
GB - Regno Unito 125
SE - Svezia 54
DE - Germania 48
CN - Cina 44
IT - Italia 39
SG - Singapore 36
HK - Hong Kong 33
FI - Finlandia 21
FR - Francia 20
UA - Ucraina 17
TR - Turchia 10
BG - Bulgaria 8
RU - Federazione Russa 5
IN - India 4
MY - Malesia 4
CA - Canada 3
LT - Lituania 3
AU - Australia 2
BE - Belgio 2
ID - Indonesia 2
NL - Olanda 2
AT - Austria 1
BR - Brasile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IL - Israele 1
MU - Mauritius 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
Totale 1.489
Città #
Fairfield 180
Woodbridge 111
Southend 101
Ashburn 91
Houston 87
Chandler 79
Seattle 65
Cambridge 59
Santa Clara 55
Wilmington 49
Jacksonville 37
Nyköping 35
Hong Kong 32
Ann Arbor 31
Singapore 30
Dearborn 21
Helsinki 17
San Diego 12
Beijing 8
Princeton 8
Sofia 8
Eugene 7
Bremen 6
Modena 6
Frankfurt am Main 5
London 5
Shanghai 5
Mirandola 4
Falls Church 3
Izmir 3
Milan 3
San Giuliano Milanese 3
Boardman 2
Brussels 2
Genoa 2
Guntur 2
Indiana 2
Jakarta 2
Mascali 2
Nanjing 2
New York 2
Segrate 2
Sydney 2
Toronto 2
Turin 2
Albuquerque 1
As 1
Bangalore 1
Baotou 1
Belgrade 1
Central 1
Changsha 1
Chicago 1
Chiswick 1
Dallas 1
Dongguan 1
Edinburgh 1
Frattamaggiore 1
Fremont 1
Guangzhou 1
Hangzhou 1
Jinan 1
Kilburn 1
Kuala Lumpur 1
Lisbon 1
Los Angeles 1
Manchester 1
Mumbai 1
Munich 1
Nanning 1
Ottawa 1
Panama City 1
Parma 1
Philadelphia 1
Phoenix 1
Piacenza 1
Prague 1
Prescot 1
Quito 1
Redwood City 1
San Jose 1
San José 1
Sassuolo 1
Shenyang 1
Stanford 1
Tel Aviv 1
Washington 1
Zhoushan 1
Totale 1.235
Nome #
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 266
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi 255
Bilateral osteonecrosis of the femoral head in an adult man affected by congenital estrogen deficiency 205
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up 198
Bendamustine salvage therapy for T cell neoplasms 182
Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma 181
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma 107
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial 98
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax Sensitivity 15
Totale 1.507
Categoria #
all - tutte 6.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020213 0 0 0 0 21 47 43 32 35 11 15 9
2020/2021346 25 22 42 43 49 32 12 25 20 38 27 11
2021/2022202 4 30 24 11 7 9 13 13 23 9 38 21
2022/2023203 23 31 12 22 32 25 4 22 18 1 7 6
2023/2024114 1 4 8 10 25 6 24 13 1 2 7 13
2024/2025123 9 10 15 31 58 0 0 0 0 0 0 0
Totale 1.507